Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SOPHiA GENETICS (SOPH) Other Operating Expenses (2020 - 2025)

Historic Other Operating Expenses for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$143000.0.

  • SOPHiA GENETICS's Other Operating Expenses fell 43255.81% to -$143000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$143000.0, marking a year-over-year decrease of 43255.81%. This contributed to the annual value of $377000.0 for FY2022, which is 24907.41% up from last year.
  • According to the latest figures from Q3 2025, SOPHiA GENETICS's Other Operating Expenses is -$143000.0, which was down 43255.81% from $43000.0 recorded in Q3 2024.
  • In the past 5 years, SOPHiA GENETICS's Other Operating Expenses ranged from a high of $28.0 million in Q2 2021 and a low of -$143000.0 during Q3 2025
  • For the 5-year period, SOPHiA GENETICS's Other Operating Expenses averaged around $2.6 million, with its median value being $24000.0 (2021).
  • Its Other Operating Expenses has fluctuated over the past 5 years, first plummeted by 225000.0% in 2022, then surged by 96744.19% in 2023.
  • SOPHiA GENETICS's Other Operating Expenses (Quarter) stood at $52000.0 in 2021, then skyrocketed by 384.62% to $252000.0 in 2022, then surged by 196.03% to $746000.0 in 2023, then crashed by 94.24% to $43000.0 in 2024, then plummeted by 432.56% to -$143000.0 in 2025.
  • Its Other Operating Expenses stands at -$143000.0 for Q3 2025, versus $43000.0 for Q3 2024 and $746000.0 for Q3 2023.